Cabaletta Bio, Inc. (CABA) Press Releases https://www.cabalettabio.com/news-media/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/cabalettabio/files/theme/images/logo-sm-new.png Cabaletta Bio, Inc. Logo https://www.cabalettabio.com Equisolve Investor Relations Suite <![CDATA[Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update]]> https://www.cabalettabio.com/news-media/press-releases/detail/143/cabaletta-bio-reports-fourth-quarter-and-full-year-2025 Mon, 23 Mar 26 07:30:00 -0400 https://www.cabalettabio.com/news-media/press-releases/detail/143/cabaletta-bio-reports-fourth-quarter-and-full-year-2025 <![CDATA[Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference]]> https://www.cabalettabio.com/news-media/press-releases/detail/142/cabaletta-bio-to-participate-in-the-td-cowen-46th-annual Tue, 24 Feb 26 08:00:00 -0500 https://www.cabalettabio.com/news-media/press-releases/detail/142/cabaletta-bio-to-participate-in-the-td-cowen-46th-annual <![CDATA[Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026]]> https://www.cabalettabio.com/news-media/press-releases/detail/141/cabaletta-bio-to-participate-in-the-guggenheim-emerging Thu, 05 Feb 26 08:00:00 -0500 https://www.cabalettabio.com/news-media/press-releases/detail/141/cabaletta-bio-to-participate-in-the-guggenheim-emerging <![CDATA[Cabaletta Bio Announces 2026 Strategic Priorities]]> https://www.cabalettabio.com/news-media/press-releases/detail/140/cabaletta-bio-announces-2026-strategic-priorities Mon, 12 Jan 26 08:00:00 -0500 https://www.cabalettabio.com/news-media/press-releases/detail/140/cabaletta-bio-announces-2026-strategic-priorities <![CDATA[Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update]]> https://www.cabalettabio.com/news-media/press-releases/detail/139/cabaletta-bio-reports-third-quarter-2025-financial-results Mon, 10 Nov 25 07:30:00 -0500 https://www.cabalettabio.com/news-media/press-releases/detail/139/cabaletta-bio-reports-third-quarter-2025-financial-results <![CDATA[Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December]]> https://www.cabalettabio.com/news-media/press-releases/detail/138/cabaletta-bio-to-participate-in-upcoming-investor Tue, 04 Nov 25 08:00:00 -0500 https://www.cabalettabio.com/news-media/press-releases/detail/138/cabaletta-bio-to-participate-in-upcoming-investor <![CDATA[Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025]]> https://www.cabalettabio.com/news-media/press-releases/detail/137/cabaletta-bio-presents-positive-clinical-data-and Mon, 27 Oct 25 07:00:00 -0400 https://www.cabalettabio.com/news-media/press-releases/detail/137/cabaletta-bio-presents-positive-clinical-data-and <![CDATA[Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant]]> https://www.cabalettabio.com/news-media/press-releases/detail/136/cabaletta-bio-announces-appointment-of-steve-gavel-as-chief Tue, 14 Oct 25 08:00:00 -0400 https://www.cabalettabio.com/news-media/press-releases/detail/136/cabaletta-bio-announces-appointment-of-steve-gavel-as-chief <![CDATA[Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress]]> https://www.cabalettabio.com/news-media/press-releases/detail/135/cabaletta-bio-presents-first-rese-cel-data-with-no Thu, 09 Oct 25 12:00:00 -0400 https://www.cabalettabio.com/news-media/press-releases/detail/135/cabaletta-bio-presents-first-rese-cel-data-with-no <![CDATA[Cabaletta Bio to Participate in Upcoming Investor Conferences in September]]> https://www.cabalettabio.com/news-media/press-releases/detail/134/cabaletta-bio-to-participate-in-upcoming-investor Wed, 27 Aug 25 08:00:00 -0400 https://www.cabalettabio.com/news-media/press-releases/detail/134/cabaletta-bio-to-participate-in-upcoming-investor